Eintrag weiter verarbeiten
Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ez...
Gespeichert in:
| Zeitschriftentitel: | Circulation |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Circulation, 133, 2016, 13 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Ovid Technologies (Wolters Kluwer Health)
|
| Schlagwörter: |
| author_facet |
Bohula, Erin A. Giugliano, Robert P. Cannon, Christopher P. Zhou, Jing Murphy, Sabina A. White, Jennifer Tershakovec, Andrew M. Blazing, Michael A. Braunwald, Eugene Bohula, Erin A. Giugliano, Robert P. Cannon, Christopher P. Zhou, Jing Murphy, Sabina A. White, Jennifer Tershakovec, Andrew M. Blazing, Michael A. Braunwald, Eugene |
|---|---|
| author |
Bohula, Erin A. Giugliano, Robert P. Cannon, Christopher P. Zhou, Jing Murphy, Sabina A. White, Jennifer Tershakovec, Andrew M. Blazing, Michael A. Braunwald, Eugene |
| spellingShingle |
Bohula, Erin A. Giugliano, Robert P. Cannon, Christopher P. Zhou, Jing Murphy, Sabina A. White, Jennifer Tershakovec, Andrew M. Blazing, Michael A. Braunwald, Eugene Circulation Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” Physiology (medical) Cardiology and Cardiovascular Medicine |
| author_sort |
bohula, erin a. |
| spelling |
Bohula, Erin A. Giugliano, Robert P. Cannon, Christopher P. Zhou, Jing Murphy, Sabina A. White, Jennifer Tershakovec, Andrew M. Blazing, Michael A. Braunwald, Eugene 0009-7322 1524-4539 Ovid Technologies (Wolters Kluwer Health) Physiology (medical) Cardiology and Cardiovascular Medicine http://dx.doi.org/10.1161/circulationaha.116.020947 Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” Circulation |
| doi_str_mv |
10.1161/circulationaha.116.020947 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Biologie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS9jaXJjdWxhdGlvbmFoYS4xMTYuMDIwOTQ3 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS9jaXJjdWxhdGlvbmFoYS4xMTYuMDIwOTQ3 |
| institution |
DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Ovid Technologies (Wolters Kluwer Health), 2016 |
| imprint_str_mv |
Ovid Technologies (Wolters Kluwer Health), 2016 |
| issn |
0009-7322 1524-4539 |
| issn_str_mv |
0009-7322 1524-4539 |
| language |
English |
| mega_collection |
Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| match_str |
bohula2016responsetoletterregardingarticleachievementofduallowdensitylipoproteincholesterolandhighsensitivitycreactiveproteintargetsmorefrequentwiththeadditionofezetimibetosimvastatinandassociatedwithbetteroutcomesinimproveit |
| publishDateSort |
2016 |
| publisher |
Ovid Technologies (Wolters Kluwer Health) |
| recordtype |
ai |
| record_format |
ai |
| series |
Circulation |
| source_id |
49 |
| title |
Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_unstemmed |
Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_full |
Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_fullStr |
Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_full_unstemmed |
Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_short |
Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_sort |
response to letter regarding article, “achievement of dual low-density lipoprotein cholesterol and high-sensitivity c-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in improve-it” |
| topic |
Physiology (medical) Cardiology and Cardiovascular Medicine |
| url |
http://dx.doi.org/10.1161/circulationaha.116.020947 |
| publishDate |
2016 |
| physical |
|
| description |
|
| container_issue |
13 |
| container_start_page |
0 |
| container_title |
Circulation |
| container_volume |
133 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792321719874093066 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:06:18.429Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Response+to+Letter+Regarding+Article%2C+%E2%80%9CAchievement+of+Dual+Low-Density+Lipoprotein+Cholesterol+and+High-Sensitivity+C-Reactive+Protein+Targets+More+Frequent+With+the+Addition+of+Ezetimibe+to+Simvastatin+and+Associated+With+Better+Outcomes+in+IMPROVE-IT%E2%80%9D&rft.date=2016-03-29&genre=article&issn=1524-4539&volume=133&issue=13&jtitle=Circulation&atitle=Response+to+Letter+Regarding+Article%2C+%E2%80%9CAchievement+of+Dual+Low-Density+Lipoprotein+Cholesterol+and+High-Sensitivity+C-Reactive+Protein+Targets+More+Frequent+With+the+Addition+of+Ezetimibe+to+Simvastatin+and+Associated+With+Better+Outcomes+in+IMPROVE-IT%E2%80%9D&aulast=Braunwald&aufirst=Eugene&rft_id=info%3Adoi%2F10.1161%2Fcirculationaha.116.020947&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792321719874093066 |
| author | Bohula, Erin A., Giugliano, Robert P., Cannon, Christopher P., Zhou, Jing, Murphy, Sabina A., White, Jennifer, Tershakovec, Andrew M., Blazing, Michael A., Braunwald, Eugene |
| author_facet | Bohula, Erin A., Giugliano, Robert P., Cannon, Christopher P., Zhou, Jing, Murphy, Sabina A., White, Jennifer, Tershakovec, Andrew M., Blazing, Michael A., Braunwald, Eugene, Bohula, Erin A., Giugliano, Robert P., Cannon, Christopher P., Zhou, Jing, Murphy, Sabina A., White, Jennifer, Tershakovec, Andrew M., Blazing, Michael A., Braunwald, Eugene |
| author_sort | bohula, erin a. |
| container_issue | 13 |
| container_start_page | 0 |
| container_title | Circulation |
| container_volume | 133 |
| description | |
| doi_str_mv | 10.1161/circulationaha.116.020947 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Biologie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS9jaXJjdWxhdGlvbmFoYS4xMTYuMDIwOTQ3 |
| imprint | Ovid Technologies (Wolters Kluwer Health), 2016 |
| imprint_str_mv | Ovid Technologies (Wolters Kluwer Health), 2016 |
| institution | DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 0009-7322, 1524-4539 |
| issn_str_mv | 0009-7322, 1524-4539 |
| language | English |
| last_indexed | 2024-03-01T11:06:18.429Z |
| match_str | bohula2016responsetoletterregardingarticleachievementofduallowdensitylipoproteincholesterolandhighsensitivitycreactiveproteintargetsmorefrequentwiththeadditionofezetimibetosimvastatinandassociatedwithbetteroutcomesinimproveit |
| mega_collection | Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| physical | |
| publishDate | 2016 |
| publishDateSort | 2016 |
| publisher | Ovid Technologies (Wolters Kluwer Health) |
| record_format | ai |
| recordtype | ai |
| series | Circulation |
| source_id | 49 |
| spelling | Bohula, Erin A. Giugliano, Robert P. Cannon, Christopher P. Zhou, Jing Murphy, Sabina A. White, Jennifer Tershakovec, Andrew M. Blazing, Michael A. Braunwald, Eugene 0009-7322 1524-4539 Ovid Technologies (Wolters Kluwer Health) Physiology (medical) Cardiology and Cardiovascular Medicine http://dx.doi.org/10.1161/circulationaha.116.020947 Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” Circulation |
| spellingShingle | Bohula, Erin A., Giugliano, Robert P., Cannon, Christopher P., Zhou, Jing, Murphy, Sabina A., White, Jennifer, Tershakovec, Andrew M., Blazing, Michael A., Braunwald, Eugene, Circulation, Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT”, Physiology (medical), Cardiology and Cardiovascular Medicine |
| title | Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_full | Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_fullStr | Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_full_unstemmed | Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_short | Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| title_sort | response to letter regarding article, “achievement of dual low-density lipoprotein cholesterol and high-sensitivity c-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in improve-it” |
| title_unstemmed | Response to Letter Regarding Article, “Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT” |
| topic | Physiology (medical), Cardiology and Cardiovascular Medicine |
| url | http://dx.doi.org/10.1161/circulationaha.116.020947 |